Antimicrobial Resistance in Escherichia coli - PubMed (original) (raw)

Review

Antimicrobial Resistance in Escherichia coli

Laurent Poirel et al. Microbiol Spectr. 2018 Jul.

Abstract

Multidrug resistance in Escherichia coli has become a worrying issue that is increasingly observed in human but also in veterinary medicine worldwide. E. coli is intrinsically susceptible to almost all clinically relevant antimicrobial agents, but this bacterial species has a great capacity to accumulate resistance genes, mostly through horizontal gene transfer. The most problematic mechanisms in E. coli correspond to the acquisition of genes coding for extended-spectrum β-lactamases (conferring resistance to broad-spectrum cephalosporins), carbapenemases (conferring resistance to carbapenems), 16S rRNA methylases (conferring pan-resistance to aminoglycosides), plasmid-mediated quinolone resistance (PMQR) genes (conferring resistance to [fluoro]quinolones), and mcr genes (conferring resistance to polymyxins). Although the spread of carbapenemase genes has been mainly recognized in the human sector but poorly recognized in animals, colistin resistance in E. coli seems rather to be related to the use of colistin in veterinary medicine on a global scale. For the other resistance traits, their cross-transfer between the human and animal sectors still remains controversial even though genomic investigations indicate that extended-spectrum β-lactamase producers encountered in animals are distinct from those affecting humans. In addition, E. coli of animal origin often also show resistances to other-mostly older-antimicrobial agents, including tetracyclines, phenicols, sulfonamides, trimethoprim, and fosfomycin. Plasmids, especially multiresistance plasmids, but also other mobile genetic elements, such as transposons and gene cassettes in class 1 and class 2 integrons, seem to play a major role in the dissemination of resistance genes. Of note, coselection and persistence of resistances to critically important antimicrobial agents in human medicine also occurs through the massive use of antimicrobial agents in veterinary medicine, such as tetracyclines or sulfonamides, as long as all those determinants are located on the same genetic elements.

PubMed Disclaimer

Similar articles

Cited by

References

    1. Kaper JB, Nataro JP, Mobley HL. 2004. Pathogenic Escherichia coli. Nat Rev Microbiol 2:123–140 10.1038/nrmicro818. [PubMed] - DOI - PubMed
    1. Köhler CD, Dobrindt U. 2011. What defines extraintestinal pathogenic Escherichia coli? Int J Med Microbiol 301:642–647 10.1016/j.ijmm.2011.09.006. [PubMed] - DOI - PubMed
    1. Johnson JR, Russo TA. 2005. Molecular epidemiology of extraintestinal pathogenic (uropathogenic) Escherichia coli. Int J Med Microbiol 295:383–404 10.1016/j.ijmm.2005.07.005. [PubMed] - DOI - PubMed
    1. Izzo MM, Kirkland PD, Mohler VL, Perkins NR, Gunn AA, House JK. 2011. Prevalence of major enteric pathogens in Australian dairy calves with diarrhoea. Aust Vet J 89:167–173 10.1111/j.1751-0813.2011.00692.x. [PubMed] - DOI - PMC - PubMed
    1. Kolenda R, Burdukiewicz M, Schierack P. 2015. A systematic review and meta-analysis of the epidemiology of pathogenic Escherichia coli of calves and the role of calves as reservoirs for human pathogenic E. coli. Front Cell Infect Microbiol 5:23 10.3389/fcimb.2015.00023. [PubMed] - DOI - PMC - PubMed

Publication types

MeSH terms

Substances

LinkOut - more resources